IMMU-67. On-Treatment Spatiotemporal Profiling of Glioblastoma During Oncolytic ImmunoTherapy
Charles Couturier(Broad Institute), Nathalie Y.R. Agar(Texas Endosurgery Institute), Jennifer Gantchev(Center for Pain and the Brain), Kenny Yu(Memorial Sloan Kettering Cancer Center), Alicia D. D’Souza(Massachusetts Institute of Technology), Gerard Baquer(Center for Pain and the Brain), Michael S. Regan(Brigham and Women's Hospital), E Antonio Chiocca(Brigham and Women's Hospital), Atul Deshpande(University of California, Irvine), Md Amin Hossain(Justus-Liebig-Universität Gießen), G B M TeamLab(Breakthrough), Julia Rose Bonney(Brigham and Women's Hospital), Forest M. White(Center for Cancer Research), Kaitlyn Bootz(Brigham and Women's Hospital), Peter Zhang(Acadia Pharmaceuticals (United States))
Cited by 0
Related Papers
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
|Nature Communications|2020|601
Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules
|Molecular & Cellular Proteomics|2005|547